RAD April 2022 Conference Abstracts and Posters
224 - Baseline Patient Demographics and Comorbidities in Patients With Atopic Dermatitis From the GLOBOSTAD Registry
Piergiacomo Calzavara-Pinton, Jarmila Čelakovská, Hilde Lapeere, Mona Al-Ahmad, Chia-Yu Chu, Jiangming Wu, Marius Ardeleanu, Zafer E. Ozturk
225 - Is the severity of atopic dermatitis associated with a higher frequency of skin infections?
Jorge A. Ríos-Duarte MD, Jonathan I. Silverberg MD, PhD, MPH
228 - Feasibility of a novel, non-invasive sample collection technique to develop a molecular test guiding therapeutic selection for patients with atopic dermatitis and psoriasis
Ann P. Quick, Aaron S. Farberg, Matthew S. Goldberg, Jeff Wilkinson, Jonathan I. Silverberg
229 - Dupilumab Treatment Improved Sleep Quality in Moderate-to-Severe Atopic Dermatitis in Children Aged 6 Months to 5 Years and Their Caregivers
Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried, Michael J. Cork, Andreas Wollenberg, Peter D. Arkwright, Haixin Zhang, Zhixiao Wang, Ainara R. Marco
230 - A Novel Digital Therapeutic Intervention to Improve Symptoms of Atopic Dermatitis: A Feasibility Study
Gudmundsdottir SL, Ballarini T, Ámundadóttir ML, Mészáros J, Eysteinsdottir JH, Thorleifsdottir RH, Ulfsdottir H, Hrafnkelsdottir SK, Bragadottir HB, Helgadottir H, Oddsson S, Silverberg J
231 - Risk factors and temporal associations of progression of the atopic march in children with atopic dermatitis
Junwen Deng BA, Varsha Parthasarathy BS, Zachary Bordeaux BS, Matthew Taylor BA, Melika Marani BS, Kevin Lee BS, Waleed Adawi MS, Anusha Kambala, Hannah L. Cornman, Joseph K. Canner MSH, Thomas Pritchard MPH, Ali Alajmi MD, Olusola O. Oladipo PhD, Shawn G. Kwatra MD
232 - Oral Difelikefalin Improves Itch and Quality of Life in Subjects With Itch-Dominant Atopic Dermatitis: Subgroup Analysis of a Randomized, Phase 2 Study
Mark Lebwohl, MD; Brian Kim, MD, MRT; Joana Goncalves, MD; Kristine Nograles, MD; Catherine Munera, PhD; Emma Guttman-Yassky, MD, PhD
233 - Oral Difelikefalin Improves Itch and Inflammatory Biomarkers in Atopic Dermatitis Subjects With Moderate-to-Severe Pruritus
Emma Guttman-Yassky, MD, PhD; Paola Facheris, MD; Joel Correa Da Rosa, PhD; Yeriel Estrada, BA; Eden David, BA; Ana Pavel, PhD; Swaroop Bose, MS; Joana Goncalves, MD; Kristine Nograles, MD; Brian Kim, MD, MRT; Mark Lebwohl, MD
234 - A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel 5-Group Study of Sphingosine-1-Phosphate Receptor Modulator BMS-986166 or Bruton’s Tyrosine Kinase Inhibitor Branebrutinib for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis
Emma Guttman-Yassky, M.D., Ph.D., Leon Carayannopoulos, M.D., Ph.D., Fareeda Hosein, M.D., Dennis M. Grasela, Pharm.D., Ph.D., Jeffrey Melin, M.D., M.P.H., Josephine Reyes, D.V.M., David Zammit, Ph.D., M.B.A., Mai Carey, M.S.
235 - Abrocitinib Reduces Skin Pain in Adolescent and Adult Patients With Moderate-to-Severe Atopic Dermatitis
Jacob P. Thyssen, Anthony Bewley, Sonja Ständer, Carla Castro, Laurent Misery, Brian Kim, Pinaki Biswas, Gary Chan, Daniela E. Myers, Melissa Watkins, Justine Alderfer, Erman Guler, Jonathan I. Silverberg